• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于计算生物学方法的纳米颗粒介导的帕金森病抑制作用

Nano-particle mediated inhibition of Parkinson's disease using computational biology approach.

机构信息

State Key Laboratory of Microbial Metabolism and School of life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.

Sabanci University Nanotechnology Research and Application Center, Orta Mah. Tuzla, 34956, Istanbul, Turkey.

出版信息

Sci Rep. 2018 Jun 15;8(1):9169. doi: 10.1038/s41598-018-27580-1.

DOI:10.1038/s41598-018-27580-1
PMID:29907754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6003935/
Abstract

Parkinson's disease (PD) arises as neurodegenerative disorder and characterized by progressive deterioration of motor functions due to forfeiture of dopamine-releasing neurons. During PD, neurons at stake loss their functionality that results into cognition impairment and forgetfulness, commonly called as dementia. Recently, nanoparticles (NPs) have been reported for easy drug delivery through blood-brain barrier (BBB) into the central nervous system (CNS) against the conventional drug delivery systems. However, present study attempted to elucidate the α-synuclein activity, a major factor casing PD, in presence of its inhibitor cerium oxide (CeO) nanoparticle via computational biology approach. A computational analysis was also conducted for the α-synuclein activity with biocompatible metal NPs such as GOLD NPs and SPIONs to scrutinize the efficacy and degree of inhibition induced by the CeO NP. The obtained results concluded that CeO NP fit best in the active site of α-synuclein with good contacts and interaction, and potentially inhibited the PD against L-DOPA drug selected as positive control in the designed PD biochemical pathway. Hence, CeO NP has been purposed as potential inhibitor of α-synuclein and can be employed as nano-drug against the PD.

摘要

帕金森病(PD)是一种神经退行性疾病,其特征是由于多巴胺释放神经元丧失,运动功能逐渐恶化。在 PD 中,受影响的神经元丧失了功能,导致认知障碍和健忘,通常称为痴呆。最近,纳米粒子(NPs)已被报道用于通过血脑屏障(BBB)轻松将药物递送至中枢神经系统(CNS),以替代传统的药物递送系统。然而,本研究试图通过计算生物学方法阐明α-突触核蛋白(α-synuclein)的活性,这是导致 PD 的主要因素,同时存在其抑制剂氧化铈(CeO)纳米颗粒。还进行了计算分析,以研究生物相容性金属 NPs(如金纳米颗粒(GOLD NPs)和超顺磁氧化铁纳米颗粒(SPIONs))对α-突触核蛋白活性的影响,以仔细检查 CeO NP 诱导的疗效和抑制程度。所得结果表明,CeO NP 与α-突触核蛋白的活性位点最佳匹配,具有良好的接触和相互作用,并且可能抑制了 L-DOPA 药物选择的 PD,L-DOPA 药物作为设计的 PD 生化途径中的阳性对照。因此,CeO NP 已被提议为α-突触核蛋白的潜在抑制剂,并可作为纳米药物用于治疗 PD。

相似文献

1
Nano-particle mediated inhibition of Parkinson's disease using computational biology approach.基于计算生物学方法的纳米颗粒介导的帕金森病抑制作用
Sci Rep. 2018 Jun 15;8(1):9169. doi: 10.1038/s41598-018-27580-1.
2
Cerium oxide nanoparticles modulating the Parkinson's disease conditions: From the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles.氧化铈纳米颗粒对帕金森病病情的调节作用:从α-突触核蛋白结构角度及氧化铈纳米颗粒的抗氧化特性
Heliyon. 2023 Oct 31;10(1):e21789. doi: 10.1016/j.heliyon.2023.e21789. eCollection 2024 Jan 15.
3
Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity.氧化铈纳米颗粒减轻了α-突触核蛋白的淀粉样形成和相关的细胞毒性。
Int J Nanomedicine. 2019 Aug 29;14:6989-7000. doi: 10.2147/IJN.S220380. eCollection 2019.
4
Cerium Oxide Nanoparticles Rescue α-Synuclein-Induced Toxicity in a Yeast Model of Parkinson's Disease.氧化铈纳米颗粒可挽救帕金森病酵母模型中α-突触核蛋白诱导的毒性。
Nanomaterials (Basel). 2020 Jan 29;10(2):235. doi: 10.3390/nano10020235.
5
Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.载双药脂质纳米粒透过血脑屏障在鱼藤酮诱导的帕金森病小鼠模型中赋予增强的神经保护作用。
ACS Chem Neurosci. 2016 Dec 21;7(12):1658-1670. doi: 10.1021/acschemneuro.6b00207. Epub 2016 Oct 3.
6
Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.载多巴胺纳米粒经血脑屏障递送至帕金森病大鼠模型中可逆转其功能缺陷。
ACS Nano. 2015 May 26;9(5):4850-71. doi: 10.1021/nn506408v. Epub 2015 Apr 22.
7
Design, synthesis and structure-activity evaluation of novel 2-pyridone-based inhibitors of α-synuclein aggregation with potentially improved BBB permeability.新型基于 2-吡啶酮的α-突触核蛋白聚集抑制剂的设计、合成与构效关系评价,具有潜在改善血脑屏障通透性。
Bioorg Chem. 2021 Dec;117:105472. doi: 10.1016/j.bioorg.2021.105472. Epub 2021 Nov 6.
8
High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.高通量测序鉴定在果蝇帕金森病模型早期通过靶向神经活性配体受体相互作用途径介导α-突触核蛋白毒性的微小RNA
PLoS One. 2015 Sep 11;10(9):e0137432. doi: 10.1371/journal.pone.0137432. eCollection 2015.
9
Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells.硅纳米颗粒诱导 PC12 细胞中的α-突触核蛋白诱导和聚集。
Chem Biol Interact. 2016 Oct 25;258:197-204. doi: 10.1016/j.cbi.2016.09.006. Epub 2016 Sep 6.
10
A facile approach for synthesis of nano-CeO particles loaded co-polymer matrix and their colossal role for blood-brain barrier permeability in Cerebral Ischemia.一种简便的方法来合成纳米 CeO 粒子负载的共聚物基质,以及它们在脑缺血中对血脑屏障通透性的巨大作用。
J Photochem Photobiol B. 2018 Oct;187:184-189. doi: 10.1016/j.jphotobiol.2018.05.003. Epub 2018 May 3.

引用本文的文献

1
Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives.帕金森病纳米技术的最新进展:诊断、治疗及未来展望。
Front Med (Lausanne). 2025 Jan 22;12:1535682. doi: 10.3389/fmed.2025.1535682. eCollection 2025.
2
Periodic Table of Immunomodulatory Elements and Derived Two-Dimensional Biomaterials.免疫调节元素周期表及衍生的二维生物材料
Adv Sci (Weinh). 2025 Feb;12(6):e2406324. doi: 10.1002/advs.202406324. Epub 2025 Jan 3.
3
Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review.

本文引用的文献

1
Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases.简明综述:神经退行性疾病中的间充质干细胞
Stem Cells. 2017 Aug;35(8):1867-1880. doi: 10.1002/stem.2651. Epub 2017 Jun 30.
2
The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.用于蛋白质的OPLS(液体模拟优化势)势函数、环肽和克拉宾晶体的能量最小化。
J Am Chem Soc. 1988 Mar 1;110(6):1657-66. doi: 10.1021/ja00214a001.
3
Nanoparticles in practice for molecular-imaging applications: An overview.
用于革命性药物递送应用的无机纳米颗粒探索:批判性综述
Discov Nano. 2023 Dec 19;18(1):157. doi: 10.1186/s11671-023-03943-0.
4
Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.纳米技术赋能的神经退行性疾病治疗策略。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1907. doi: 10.1002/wnan.1907. Epub 2023 May 30.
5
Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform.聚合物纳米粒子作为生物兼容平台在脑癌和神经退行性疾病治疗中的应用。
Molecules. 2023 Jan 14;28(2):841. doi: 10.3390/molecules28020841.
6
Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders.各类纳米材料在神经系统疾病治疗中的应用
Nanomaterials (Basel). 2022 Jun 22;12(13):2140. doi: 10.3390/nano12132140.
7
Evaluation of anti-EGFR-iRGD recombinant protein with GOLD nanoparticles: synergistic effect on antitumor efficiency using optimized deep neural networks.用金纳米颗粒评估抗表皮生长因子受体-iRGD重组蛋白:利用优化的深度神经网络对抗肿瘤效率的协同作用。
RSC Adv. 2019 Jun 19;9(34):19261-19270. doi: 10.1039/c9ra01975h.
8
Luminescent chitosan/carbon dots as an effective nano-drug carrier for neurodegenerative diseases.发光壳聚糖/碳点作为神经退行性疾病的有效纳米药物载体
RSC Adv. 2020 Jun 25;10(41):24386-24396. doi: 10.1039/d0ra04599c. eCollection 2020 Jun 24.
9
Advances in Non-Animal Testing Approaches towards Accelerated Clinical Translation of Novel Nanotheranostic Therapeutics for Central Nervous System Disorders.用于中枢神经系统疾病的新型纳米诊疗疗法加速临床转化的非动物测试方法进展
Nanomaterials (Basel). 2021 Oct 7;11(10):2632. doi: 10.3390/nano11102632.
10
Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.阳离子碳硅烷树状大分子可预防帕金森病患者特异性多巴胺神经元中异常α-突触核蛋白的积累。
Biomacromolecules. 2021 Nov 8;22(11):4582-4591. doi: 10.1021/acs.biomac.1c00884. Epub 2021 Oct 6.
纳米颗粒在分子成像应用中的实践:概述。
Acta Biomater. 2016 Sep 1;41:1-16. doi: 10.1016/j.actbio.2016.06.003. Epub 2016 Jun 2.
4
Role of neuroinflammation in neurodegenerative diseases (Review).神经炎症在神经退行性疾病中的作用(综述)
Mol Med Rep. 2016 Apr;13(4):3391-6. doi: 10.3892/mmr.2016.4948. Epub 2016 Feb 29.
5
Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns.神经退行性疾病的人类DNA甲基化组呈现出常见的表观基因组模式。
Transl Psychiatry. 2016 Jan 19;6(1):e718. doi: 10.1038/tp.2015.214.
6
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.使用分子动力学自由能微扰和OPLS力场预测绝对溶剂化自由能
J Chem Theory Comput. 2010 May 11;6(5):1509-19. doi: 10.1021/ct900587b. Epub 2010 Apr 14.
7
Boolean network model for GPR142 against Type 2 diabetes and relative dynamic change ratio analysis using systems and biological circuits approach.基于系统和生物电路方法的GPR142抗2型糖尿病的布尔网络模型及相对动态变化率分析
Syst Synth Biol. 2015 Jun;9(1-2):45-54. doi: 10.1007/s11693-015-9163-0. Epub 2015 Mar 14.
8
Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process.金纳米粒子/纳米棒的蛋白冠组成影响淀粉样β纤维形成过程。
Nanoscale. 2015 Mar 21;7(11):5004-13. doi: 10.1039/c4nr06009a.
9
Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.5-(4-羟基-3-二甲氧基亚苄基)-噻唑烷酮在MPTP诱导的小鼠帕金森病模型中的神经保护作用
Neuropharmacology. 2015 Jun;93:209-18. doi: 10.1016/j.neuropharm.2015.01.030. Epub 2015 Feb 11.
10
Network biology in medicine and beyond.医学及其他领域的网络生物学。
Circ Cardiovasc Genet. 2014 Aug;7(4):536-47. doi: 10.1161/CIRCGENETICS.113.000123.